SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-014908
Filing Date
2024-02-16
Accepted
2024-02-16 16:15:23
Documents
17
Period of Report
2024-02-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea193928-8k_180life.htm   iXBRL 8-K 52334
2 SECOND AMENDMENT TO 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN ea193928ex10-1_180life.htm EX-10.1 7467
3 SECOND AMENDED AND RESTATED 180 LIFE SCIENCES CORP. 2022 OMNIBUS INCENTIVE PLAN ea193928ex10-2_180life.htm EX-10.2 117571
  Complete submission text file 0001213900-24-014908.txt   433288

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE atnf-20240216.xsd EX-101.SCH 3787
5 XBRL DEFINITION FILE atnf-20240216_def.xml EX-101.DEF 26629
6 XBRL LABEL FILE atnf-20240216_lab.xml EX-101.LAB 36680
7 XBRL PRESENTATION FILE atnf-20240216_pre.xml EX-101.PRE 25253
18 EXTRACTED XBRL INSTANCE DOCUMENT ea193928-8k_180life_htm.xml XML 5745
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

IRS No.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 24648518
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)